Robert J. Snyder, D.P.M. MSc, C.W.S.
- Diplomat, American Board of Podiatric Surgery, Board Certified in Foot and Ankle Surgery
- Diplomat, American Board of Wound Management, Certified Wound Specialist (C.W.S.)
- Fellow, American College of Foot and Ankle Surgeons
- Immediate- Past President and Board Member of Association for the Advancement of Wound Care (AAWC)
- Past President and Board Member of American Board of Wound Management (ABWM)
- Jackson North
- Hialeah Hospital
- Mt Sinai
- University Of Miami
- Coral Springs/Broward Health
- University Hospital & Medical Center
- Northwest Medical Center
- New York College of Podiatric Medicine, New York, NY
- Cardiff University, University of Wales School of Medicine, UK
- Jewish Memorial Hospital, New York, NY
- Professor & Director of Clinical Research Barry University SPM, Brand Research Center
- Adjunct Professor, Temple University School of Podiatric Medicine
- Medical Advisory Board & Wound Care Course Lecturer Healogics
- Editorial Board: Ostomy Wound Management, Wounds, Podiatry, Management
- Periodic Review: NEJM, Lancet
- Snyder RJ, Fife C, Moore Z. Components and Quality Measures of DIME (Devitalized Tissue, Infection/Inflammation, Moisture Balance, and Edge Preparation) in Wound Care. Advances in Skin & Wound Care. 2016: 205-215.
- Snyder RJ, Shimozaki K, Tallis A, et al. A Prospective, Randomized, Controlled Evaluation of the Use of Dehydrated Amniotic Membrane Allograft Compared to Standard of Care for the Closure of Chronic Diabetic Foot Ulcers. WOUNDS 2016; 28(3) 40-48.
- Snyder RJ. A Patient-Centered Collaborative Approach to Care. Current Dialogues in Wound Management. 2016; 2(1).
- Snyder RJ, Cuffy, CA, Glick B, Ead, J. Dehydrated Human Amnion/Chorion Membrane as Adjunctive Therapy in the Multidisciplinary Treatment of Pyoderma Gangrenosum: A Case Report. Ostomy Wound Management. 2015; 61(9):40-49.
- Snyder RJ. Ulcerations Caused by Chronic Venous Insufficiency. Current Dialogues in Wound Management September 2015;1 (3).
- Rogers L, Snyder RJ. Review of the DFU Off-loading Consensus of 2014. Podiatry Management. 2015; 105-114.
- Snyder RJ. Wound Bed Preparation: the DIME. Current Dialogues in Wound Management. 2015; 1(2).
- Snyder RJ. Are Current Chronic Wounds a Factor of Time or Aberrant Wound Biochemistry? Current Dialogues in Wound Management. 2015;1 (1).
- Zelen CM, Snyder RJ, Serena TE, Li, WW. The Use of Human Amnion/Chorion Membrane in the Clinical Setting for Lower Extremity Repair: A Review. Clinics in Podiatric Medicine and Surgery. 2015; 32(1): 135-146.
- Snyder RJ, Frykberg, RG, Rogers LC etal. The Management of Diabetic Foot Ulcers Through Optimal Off-Loading: Building consensus guidelines and practical recommendations to improve outcomes. 2014; JAPMA 104(6):555-567.
- Vazales R, Constant D, Snyder RJ. A rare case of aggressive digital adenocarcinoma of the lower extremity, masquerading as an ulcerative lesion that clinically favored benignancy. Healthcare 2014; 2 315-323.
- Moradi M, Snyder RJ, Cala M et al. Long-Standing Non healing Charcot Foot Ulcers That Fail Conservative Care: Is Major Amputation Always the Solution? WOUNDS 2014; 26(8): 207-213.
- Armstrong, DG, Hanft, JR, Snyder, RJ et al. Effect of oral nutritional supplementation on wound healing in diabetic foot ulcers: a prospective randomized controlled trial. Diabetic Medicine 2014; 31:1069-1077.
- Snyder, RJ, Vazales, R. Acroangiodermatitis (Pseudo-Kaposi’s Sarcoma) Seen in Conjunction with Marfan Syndrome and a Hypercoaguable State: Is There a Link? Wounds. 2014; 26(3):72-76.
- Snyder, RJ, Serena, TE, Zelen, CM. A prospective, randomized comparative study of weekly versus biweekly application of dehydrated human anion/chorion membrane allograft in the management of diabetic foot ulcers. International Wound Journal. 2014; 10.1111/ 12242
- Snyder, RJ, Cullen, B, Nisbet, LT. An audit to assess the perspectives of US wound care specialists regarding the importance of proteases in wound healing and wound assessment. International Wound Journal. 2013; 10:653-660
- Snyder, RJ, Kirsner, RS, Marston, WA et al. Durability of healing from spray-applied cell therapy with human allogeneic fibroblasts and keratinocytes for the treatment of chronic venous leg ulcers: A 6-month follow-up. Wound Repair and Regeneration. 2013;21:682-687
- Snyder RJ, Cook RG. Particularities in wound healing in diabetic neuro-ischemic foot wounds: why the angiosome model may be useful. In: Angiosomes Applications in Critical Limb Ischemia: In search of relevance. (V. Alexandrescu, (Ed)). 2013. Edizioni Minerva Medica: Turin, Italy.
- Wilson TC, Snyder RJ, Southerland C. Bullosis Diabeticum: Is there a correlation between hyperglycemia and this symptomalogy? Wounds. 2012;24(12):350-355
- Snyder RJ, Fetterolf DE. Scientific and clinical support for the use of dehydrated amniotic membrane in wound management. Wounds. October 2012;24(10): 299-307
- Snyder RJ, Cullen B, Nisbet LT. An audit to assess the perspectives of US sound Care specialists regarding the importance of proteases in wound healing and wound assessment. International Wound Journal. 2012; doi: 10.1111/j.1742-481X.2012.01040.x
- Badahdah H, Snyder RJ, O’Connor C. et al. Mixed Etiology Hydroxyurea- Related lower leg ulcer that masqueraded as sequelae from sickle cell disease and venous insufficiency. Wounds. 2012;24(9): 254-257
- Kirsner, RS, Marston WA, Snyder RJ et al. Spray-applied cell therapy with human allogeneic fibroblasts and keratinocytes for the treatment of chronic venous leg ulcers: a phase 2, multicentre, double-blind, randomized, placebo-controlled trial. The Lancet. 15, 2012; 380 (9846): 977-985
- Sibald R, Snyder RJ, Botros M, et al. Role of a point –of-care protease activity diagnostic test in Canadian clinical practice: A Canadian Expert Consensus. Advances in Skin & Wound Care. 2012;25(6): 267-275
- Serena T, Bates-Jensen B, Carter MJ, Cordrey R, Snyder RJ, et al. Consensus principles for wound care research obtained using a Delphi process. Wound Repair and Regeneration. 2012 ;20(3) : 284-293
Scientific and Research Presentations:
Dr Snyder is a world renown expert on would healing and is in high demand as an expert speaker. Over the past decade he has been a regular presenter for the European Wound Management Association and at the Symposium on Advanced Wound Care
Research Projects Serving as Principal Investigator:
Dr Snyder is a skilled clinical researcher serving as the Principal Investigator on many clinical trials. He is currently involved as the Principal Investigator on the following clinical trials:
- DermaSciences, Protocol Number DSC 127-2012-01 “A Randomized, Double-Blind, Parallel-group, Vehicle-controlled Phase 3 Clinical Trial to Evaluate the efficacy and Safety of DSC127 in Treating Non-healing Foot Ulcers in Subjects with Diabetes Mellitus” Present
- Xoma, LLC, Protocol X052170 “An Open-Label, Proof of Concept Study of Gevokizumab in the Treatment of the Acute, Inflammatory Phase of Pyoderma Gangrenosum” Present
- SanuWave, Protocol SAN12-DERM02 “A Double-Blind, Multi-center, Randomized, Sham-Controlled, Parallel Group Comparison of the dermaPACE® (pulse Acoustic Cellular Expression) Device in Conjunction with Standard of Care Versus Standard of Care Alone in the Treatment of Diabetic Foot Ulcers” October 2013 - Present
- CoDa Therapeutic, Protocol Number NEX-ULC-011 “A Randomized, Prospective, Double-blind, Vehicle-controlled, Dose-ranging, Multi-center Study to Assess the Safety and Clinical Effect of Nexagon® (NEXAGON) in the Treatment of Subjects with a Diabetic Foot Ulcer” - Present
- Macrocure , Protocol Number MC-102 CureXcell™ “A Phase III, Multinational, Multicenter, Randomized, Double-Blind, Parallel-Group, Sham-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell™ as an adjunct to Good Wound Care Measures in Treating Lower Extremity Chronic Ulcers in Adults with Diabetes Mellitus” October 2013 - Present